CN101056875A - 被取代的苯基氨基噻唑类化合物以及其应用 - Google Patents
被取代的苯基氨基噻唑类化合物以及其应用 Download PDFInfo
- Publication number
- CN101056875A CN101056875A CNA2005800381572A CN200580038157A CN101056875A CN 101056875 A CN101056875 A CN 101056875A CN A2005800381572 A CNA2005800381572 A CN A2005800381572A CN 200580038157 A CN200580038157 A CN 200580038157A CN 101056875 A CN101056875 A CN 101056875A
- Authority
- CN
- China
- Prior art keywords
- compound
- amino
- group
- hydroxyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
实施例序号 | EC50A1[nM](1μM福斯高林) | EC50A2a[nM] | EC50A2b[nM] |
2 | 9.9 | 747 | 6.1 |
8 | 1 | 300 | 1 |
10 | 2 | >200 | 1 |
13 | 0.2 | 236 | 0.1 |
21 | 0.7 | 103 | 0.5 |
26 | 23 | >3000 | 74 |
35 | 0.4 | 142 | 0.3 |
39 | 0.3 | 1200 | 1.4 |
44 | 0.6 | 140 | 0.3 |
48 | 0.4 | 140 | 0.1 |
70 | 2.3 | >3000 | 28 |
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004042607A DE102004042607A1 (de) | 2004-09-03 | 2004-09-03 | Substituierte Phenylaminothiazole und ihre Verwendung |
DE102004042607.4 | 2004-09-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101056875A true CN101056875A (zh) | 2007-10-17 |
Family
ID=35852458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2005800381572A Pending CN101056875A (zh) | 2004-09-03 | 2005-08-30 | 被取代的苯基氨基噻唑类化合物以及其应用 |
Country Status (24)
Country | Link |
---|---|
US (1) | US8691850B2 (zh) |
EP (1) | EP1812430B1 (zh) |
JP (1) | JP4999691B2 (zh) |
KR (1) | KR20070057235A (zh) |
CN (1) | CN101056875A (zh) |
AR (1) | AR050551A1 (zh) |
AT (1) | ATE428710T1 (zh) |
AU (1) | AU2005281941A1 (zh) |
BR (1) | BRPI0514833A (zh) |
CA (1) | CA2578596C (zh) |
DE (2) | DE102004042607A1 (zh) |
EC (1) | ECSP077296A (zh) |
ES (1) | ES2324049T3 (zh) |
GT (1) | GT200500238A (zh) |
IL (1) | IL181670A0 (zh) |
MA (1) | MA28869B1 (zh) |
MX (1) | MX2007002470A (zh) |
NO (1) | NO20071343L (zh) |
PE (1) | PE20060589A1 (zh) |
SV (1) | SV2006002218A (zh) |
TW (1) | TW200621765A (zh) |
UY (1) | UY29099A1 (zh) |
WO (1) | WO2006027142A1 (zh) |
ZA (1) | ZA200701820B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102482270A (zh) * | 2009-05-27 | 2012-05-30 | 拜耳制药股份公司 | 取代的哌啶 |
CN102388040B (zh) * | 2009-01-29 | 2015-05-13 | 拜耳知识产权有限责任公司 | 烷基氨基-取代的二氰基嘧啶和它们的氨基酸酯药物前体 |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006009813A1 (de) * | 2006-03-01 | 2007-09-06 | Bayer Healthcare Ag | Verwendung von A2b/A1 Rezeptor Agonisten zur Modulation der Lipidspiegel |
DE102006042143A1 (de) * | 2006-09-08 | 2008-03-27 | Bayer Healthcare Aktiengesellschaft | Neue substituierte Bipyridin-Derivate und ihre Verwendung |
DE102006044696A1 (de) | 2006-09-22 | 2008-03-27 | Bayer Healthcare Ag | 3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung |
DE102006056740A1 (de) | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung |
DE102006056739A1 (de) | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung |
DE102007035367A1 (de) * | 2007-07-27 | 2009-01-29 | Bayer Healthcare Ag | Substituierte Aryloxazole und ihre Verwendung |
DE102007036076A1 (de) | 2007-08-01 | 2009-02-05 | Bayer Healthcare Aktiengesellschaft | Dipeptoid-Produgs und ihre Verwendung |
DE102007061764A1 (de) | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Anellierte Cyanopyridine und ihre Verwendung |
DE102007061763A1 (de) * | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Substituierte azabicyclische Verbindungen und ihre Verwendung |
DE102008008838A1 (de) * | 2008-02-13 | 2009-08-20 | Bayer Healthcare Ag | Cycloalkoxy-substituierte 4-Phenyl-3,5-dicyanopyridine und ihre Verwendung |
DE102008013587A1 (de) * | 2008-03-11 | 2009-09-17 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung |
EP2297104B1 (de) * | 2008-05-29 | 2013-08-07 | Bayer Intellectual Property GmbH | 2-alkoxy-substituierte dicyanopyridine und ihre verwendung |
DE102008062567A1 (de) * | 2008-12-16 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | Dipeptoid-Prodrugs und ihre Verwendung |
DE102010030688A1 (de) | 2010-06-30 | 2012-01-05 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Dicyanopyridine und ihre Verwendung |
EP3492106B1 (en) | 2013-08-09 | 2021-02-17 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
WO2018153900A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit sglt-2-hemmern |
WO2018153898A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Pharma Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit mineralocorticoid-rezeptor-antagonisten |
WO2018153895A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Pharma Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit einem inhibitor der neutralen endopeptidase und/oder einem angiotensin ii rezeptor-antagonisten |
WO2018153897A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Pharma Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit hcn-kanal-hemmern |
WO2018153899A1 (de) | 2017-02-22 | 2018-08-30 | Bayer Pharma Aktiengesellschaft | Selektive partielle adenosin a1 rezeptor-agonisten in kombination mit stimulatoren und/oder aktivatoren der löslichen guanylatcyclase (sgc) |
JP7323913B2 (ja) * | 2019-04-12 | 2023-08-09 | 国立大学法人 筑波大学 | 睡眠誘導剤である複素環化合物 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW299333B (zh) | 1992-12-29 | 1997-03-01 | Takeda Pharm Industry Co Ltd | |
CZ287613B6 (en) | 1994-06-16 | 2001-01-17 | Pfizer | Pyrazolo- and pyrrolopyridines and pharmaceutical preparations based thereon |
JPH09132529A (ja) | 1995-11-09 | 1997-05-20 | Ono Pharmaceut Co Ltd | 一酸化窒素合成酵素阻害剤 |
PL327938A1 (en) | 1996-01-17 | 1999-01-04 | Novo Nordisk As | Derivatives of 1,2,4-thiadiazine and 1,4-thiazine, their production and application |
JPH10324687A (ja) | 1997-02-19 | 1998-12-08 | Nippon Soda Co Ltd | ピロール化合物、製法および農園芸用殺菌剤 |
JP2002507197A (ja) | 1997-05-30 | 2002-03-05 | ビーエーエスエフ アクチェンゲゼルシャフト | 置換チオピリジン |
WO1999003861A1 (en) | 1997-07-16 | 1999-01-28 | Novo Nordisk A/S | Fused 1,2,4-thiadiazine derivatives, their preparation and use |
US6632823B1 (en) | 1997-12-22 | 2003-10-14 | Merck & Co., Inc. | Substituted pyridine compounds useful as modulators of acetylcholine receptors |
DE19834047A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
DE19943636A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943635A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943634A1 (de) | 1999-09-13 | 2001-04-12 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19947154A1 (de) | 1999-10-01 | 2001-10-04 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
WO2001062233A2 (en) | 2000-02-25 | 2001-08-30 | F. Hoffmann La Roche Ag | Adenosine receptor modulators |
PL359416A1 (en) | 2000-07-18 | 2004-08-23 | Yamanouchi Pharmaceutical Co, Ltd. | Medicine comprising dicyanopyridine derivative |
AR031176A1 (es) | 2000-11-22 | 2003-09-10 | Bayer Ag | Nuevos derivados de pirazolpiridina sustituidos con piridina |
WO2002048115A2 (en) | 2000-12-11 | 2002-06-20 | E. I. Du Pont De Nemours And Company | Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests |
DK1347971T3 (da) | 2000-12-21 | 2006-05-15 | Bristol Myers Squibb Co | Thiazolylinhibitorer af tyrosinkinaser fra Tec-familien |
DE10110438A1 (de) | 2001-03-05 | 2002-09-19 | Bayer Ag | Substituierte 2-Oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
DE10110750A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE10110747A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung |
DE10110749A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte Aminodicarbonsäurederivate |
DE10110754A1 (de) | 2001-03-07 | 2002-09-19 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
DE10115922A1 (de) | 2001-03-30 | 2002-10-10 | Bayer Ag | Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
DE10115945A1 (de) | 2001-03-30 | 2002-10-02 | Bayer Ag | Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
DE10134481A1 (de) * | 2001-07-16 | 2003-01-30 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung |
DE10238113A1 (de) | 2001-12-11 | 2003-06-18 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung |
JP2003183254A (ja) | 2001-12-20 | 2003-07-03 | Yamanouchi Pharmaceut Co Ltd | 2−アシルアミノ−3,5−ジシアノピリジン誘導体又はその塩 |
WO2003091246A1 (en) | 2002-04-26 | 2003-11-06 | Vertex Pharmaceuticals Incorporated | Pyrrole derivatives as inhibitors of erk2 and uses thereof |
DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
EP1388342A1 (en) | 2002-08-07 | 2004-02-11 | Aventis Pharma Deutschland GmbH | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
BR0313396A (pt) | 2002-08-12 | 2005-06-28 | Sugen Inc | 3-pirrolil-piridopirazóis e 3-pirrolil-indazóis, como inibidores de quinase |
MXPA05006367A (es) | 2002-12-12 | 2005-08-29 | Pharmacia Corp | Metodo de uso de compuestos de aminocianopiridina como inhibidores de cinasa-2 de proteina activada de cinasa de proteina activada por mitogeno. |
AR042667A1 (es) | 2002-12-26 | 2005-06-29 | Taisho Pharmaceutical Co Ltd | Derivados de pirrolopirimidina y pirrolopiridina sustituidos con un grupo amino ciclico |
TW200418829A (en) | 2003-02-14 | 2004-10-01 | Avanir Pharmaceutics | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
EP1667683A4 (en) | 2003-09-23 | 2009-04-29 | Merck & Co Inc | INHIBITORS OF POTASSIUM CHANNELS WITH QUINOLINE |
EP1687004A4 (en) | 2003-11-10 | 2009-04-08 | Synta Pharmaceuticals Corp | PYRIDINE COMPOUNDS |
US20050182105A1 (en) | 2004-02-04 | 2005-08-18 | Nirschl Alexandra A. | Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function |
JP2007161585A (ja) | 2004-06-25 | 2007-06-28 | Taisho Pharmaceut Co Ltd | 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体 |
DE102004032651A1 (de) | 2004-07-06 | 2006-02-16 | Bayer Healthcare Ag | Verwendung von substituierten 2-Thio-3,5-dicyano-4-phenyl-6-aminopyriden bei der Behandlung von Übelkeit und Erbrechen |
DE102006042143A1 (de) | 2006-09-08 | 2008-03-27 | Bayer Healthcare Aktiengesellschaft | Neue substituierte Bipyridin-Derivate und ihre Verwendung |
DE102006056739A1 (de) | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung |
DE102006056740A1 (de) | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung |
DE102007035367A1 (de) | 2007-07-27 | 2009-01-29 | Bayer Healthcare Ag | Substituierte Aryloxazole und ihre Verwendung |
DE102007036076A1 (de) | 2007-08-01 | 2009-02-05 | Bayer Healthcare Aktiengesellschaft | Dipeptoid-Produgs und ihre Verwendung |
DE102008013587A1 (de) | 2008-03-11 | 2009-09-17 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung |
DE102008062567A1 (de) | 2008-12-16 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | Dipeptoid-Prodrugs und ihre Verwendung |
DE102009006602A1 (de) | 2009-01-29 | 2010-08-05 | Bayer Schering Pharma Aktiengesellschaft | Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs |
-
2004
- 2004-09-03 DE DE102004042607A patent/DE102004042607A1/de not_active Withdrawn
-
2005
- 2005-08-30 WO PCT/EP2005/009316 patent/WO2006027142A1/de active Application Filing
- 2005-08-30 EP EP05776232A patent/EP1812430B1/de active Active
- 2005-08-30 AU AU2005281941A patent/AU2005281941A1/en not_active Abandoned
- 2005-08-30 KR KR1020077007526A patent/KR20070057235A/ko not_active Application Discontinuation
- 2005-08-30 ES ES05776232T patent/ES2324049T3/es active Active
- 2005-08-30 CA CA2578596A patent/CA2578596C/en not_active Expired - Fee Related
- 2005-08-30 BR BRPI0514833-2A patent/BRPI0514833A/pt not_active IP Right Cessation
- 2005-08-30 JP JP2007529331A patent/JP4999691B2/ja not_active Expired - Fee Related
- 2005-08-30 CN CNA2005800381572A patent/CN101056875A/zh active Pending
- 2005-08-30 US US11/661,820 patent/US8691850B2/en not_active Expired - Fee Related
- 2005-08-30 DE DE502005007106T patent/DE502005007106D1/de active Active
- 2005-08-30 AT AT05776232T patent/ATE428710T1/de not_active IP Right Cessation
- 2005-08-30 MX MX2007002470A patent/MX2007002470A/es not_active Application Discontinuation
- 2005-09-01 GT GT200500238A patent/GT200500238A/es unknown
- 2005-09-01 AR ARP050103664A patent/AR050551A1/es not_active Application Discontinuation
- 2005-09-02 PE PE2005001012A patent/PE20060589A1/es not_active Application Discontinuation
- 2005-09-02 SV SV2005002218A patent/SV2006002218A/es not_active Application Discontinuation
- 2005-09-02 TW TW094130123A patent/TW200621765A/zh unknown
- 2005-09-05 UY UY29099A patent/UY29099A1/es not_active Application Discontinuation
-
2007
- 2007-03-01 IL IL181670A patent/IL181670A0/en unknown
- 2007-03-01 ZA ZA200701820A patent/ZA200701820B/xx unknown
- 2007-03-02 EC EC2007007296A patent/ECSP077296A/es unknown
- 2007-03-13 NO NO20071343A patent/NO20071343L/no not_active Application Discontinuation
- 2007-03-23 MA MA29769A patent/MA28869B1/fr unknown
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102388040B (zh) * | 2009-01-29 | 2015-05-13 | 拜耳知识产权有限责任公司 | 烷基氨基-取代的二氰基嘧啶和它们的氨基酸酯药物前体 |
CN104844687A (zh) * | 2009-01-29 | 2015-08-19 | 拜耳知识产权有限责任公司 | 烷基氨基-取代的二氰基嘧啶和它们的氨基酸酯药物前体 |
CN104844687B (zh) * | 2009-01-29 | 2019-04-02 | 拜耳知识产权有限责任公司 | 烷基氨基-取代的二氰基嘧啶和它们的氨基酸酯药物前体 |
CN102482270A (zh) * | 2009-05-27 | 2012-05-30 | 拜耳制药股份公司 | 取代的哌啶 |
CN102482270B (zh) * | 2009-05-27 | 2015-02-25 | 拜耳知识产权有限责任公司 | 取代的哌啶 |
Also Published As
Publication number | Publication date |
---|---|
UY29099A1 (es) | 2006-04-28 |
TW200621765A (en) | 2006-07-01 |
CA2578596A1 (en) | 2006-03-16 |
JP4999691B2 (ja) | 2012-08-15 |
DE102004042607A1 (de) | 2006-03-09 |
IL181670A0 (en) | 2007-07-04 |
JP2008511614A (ja) | 2008-04-17 |
CA2578596C (en) | 2012-10-23 |
ES2324049T3 (es) | 2009-07-29 |
AU2005281941A1 (en) | 2006-03-16 |
ZA200701820B (en) | 2008-08-27 |
ATE428710T1 (de) | 2009-05-15 |
US20080269300A1 (en) | 2008-10-30 |
SV2006002218A (es) | 2006-10-04 |
MX2007002470A (es) | 2009-02-12 |
US8691850B2 (en) | 2014-04-08 |
GT200500238A (es) | 2006-04-10 |
KR20070057235A (ko) | 2007-06-04 |
PE20060589A1 (es) | 2006-08-12 |
ECSP077296A (es) | 2007-04-26 |
BRPI0514833A (pt) | 2008-06-24 |
WO2006027142A1 (de) | 2006-03-16 |
MA28869B1 (fr) | 2007-09-03 |
AR050551A1 (es) | 2006-11-01 |
EP1812430A1 (de) | 2007-08-01 |
DE502005007106D1 (de) | 2009-05-28 |
NO20071343L (no) | 2007-05-30 |
EP1812430B1 (de) | 2009-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101056875A (zh) | 被取代的苯基氨基噻唑类化合物以及其应用 | |
CN1165536C (zh) | 与六元杂环稠合的取代的吡唑衍生物 | |
CN1247574C (zh) | 异吲哚啉-1-酮葡糖激酶激活剂 | |
CN1324015C (zh) | 吡啶-和嘧啶-衍生物 | |
CN1133625C (zh) | 喹唑啉衍生物 | |
CN1178917C (zh) | 作为nk1受体拮抗剂前药的4-苯基-吡啶衍生物的n-氧化物 | |
CN1747926A (zh) | 取代酰胺化合物 | |
CN1617721A (zh) | 取代的2-硫代-3,5-二氰基-4-苯基-6-氨基吡啶及其用途 | |
CN1038511C (zh) | 咪唑并吡啶及其制备方法和制药的应用 | |
CN1252065C (zh) | 噌啉化合物 | |
CN101048412A (zh) | 哌啶基氨基-噻吩并[2,3-d]嘧啶化合物 | |
CN1993124A (zh) | 取代吡唑、含有这种化合物的组合物及其应用 | |
CN1617722A (zh) | 烟碱或异烟碱苯并噻唑衍生物 | |
CN1950371A (zh) | 用作组胺h3受体配体的四氢萘啶衍生物 | |
CN1638768A (zh) | 调节ppar活性的噻唑和噁唑衍生物 | |
CN1602196A (zh) | 作为腺苷调节剂的2-氨基苯并噻唑脲 | |
CN1956949A (zh) | 取代的磺酰胺 | |
CN1114506A (zh) | 杂二环磺胺衍生物和磺酸酯衍生物 | |
CN1575290A (zh) | 嘧啶化合物以及含有该化合物的药物组合物 | |
CN1934082A (zh) | 有机化合物 | |
CN1906188A (zh) | 作为igf-1r抑制剂的苯基-[4-(3-苯基-1h-吡唑-4-基)-嘧啶-2-基]-胺衍生物 | |
CN1871244A (zh) | 作为腺苷受体配体的噻唑并吡啶衍生物 | |
CN1875021A (zh) | 取代的萘啶酮衍生物 | |
CN1675189A (zh) | 苯并噻唑衍生物的新用途 | |
CN1871208A (zh) | 作为大麻素受体调节剂的芳烷基胺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1114382 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: BAYER SCHERING PHARMA AG Free format text: FORMER OWNER: BAYER HEALTHCARE AG Effective date: 20091120 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20091120 Address after: Berlin Applicant after: Bayer Schering Pharma AG Address before: Germany Leverkusen Applicant before: Bayer Healthcare AG |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20071017 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1114382 Country of ref document: HK |